Hwail Pharmaceutical Co.,Ltd. (KOSDAQ:061250)
South Korea · Delayed Price · Currency is KRW 8,740.00
-10.00 (-0.11%)
At close: Jul 31, 2026
Hwail Pharmaceutical Market Cap
Hwail Pharmaceutical has a market cap or net worth of 73.57 billion as of July 31, 2026. Its market cap has decreased by -28.17% in one year.
Market Cap
73.57B
Enterprise Value
n/a
Revenue
107.87B
Ranking
n/a
PE Ratio
18.42
Stock Price
8,740.00
ChartMarket Cap Chart
Since March 3, 2003, Hwail Pharmaceutical's market cap has increased from 24.67B to 73.57B, an increase of 198.16%. That is a compound annual growth rate of 4.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 73.57B | -24.27% |
| Dec 30, 2025 | 97.15B | -6.85% |
| Dec 30, 2024 | 104.30B | -27.25% |
| Dec 28, 2023 | 143.36B | -22.49% |
| Dec 29, 2022 | 184.96B | 7.56% |
| Dec 30, 2021 | 171.96B | -31.70% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| H.PIO | 87.82B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 85.27B |
| Daehan Nupharm | 78.60B |
| KOREA PHARMA | 76.67B |
| Sam-A Pharm. | 74.52B |
| HL GENOMICS | 70.82B |
| Optipharm.CO.,LTD | 67.70B |
| GL Pharm Tech | 63.12B |